Anju Software, a leading provider of software solutions to the life sciences industry, links with its customers’ existing tools, enabling them to expand on their existing platform and deliver a custom software experience that ideally suits their requirements.
Anju provides an integrated platform spanning clinical operations, medical affairs, and commercial divisions, including integrated data intelligence. It has combined deep industry and software domain expertise to build a next-generation platform for the life sciences sector that can scale to provide solutions that meet customers’ needs.
In an interview with Insights Success, CEO of Anju, Laurence (Larry) Birch, let us explore the parameters that led to the success of Anju.
Below are the highlights of the interview:
Please enlighten our readers about Anju Software, highlighting its significance in the modern healthcare sector.
Anju is built on a strong “customer-first” culture focused on the delivery of feature-rich, adaptable life science solutions enabling faster decision-making, and driving impactful results.
Anju provides best value solutions that span the lifecycle of clinical development through medical affairs and into commercialization to support post-market activities. Anju delivers the exceptional customer experience of smaller vendors and the feature-rich product offering of larger competitors at a fair price across three distinct service areas: eClinical, Medical Affairs, and Data Sciences.
Mr. Birch, please tell us about yourself and please highlight some of your healthcare sector experience.
I have more than three decades of life sciences, software, and global management experience. I joined Anju because it can be built into one of the leaders in the life sciences technology space. My goal is to empower our customers to help patients by applying our software in eClinical, Medical Affairs, and Data Sciences, as well as other technology-based services.
My strong track record in healthcare, life sciences, and software technology enables me to drive innovation and achieve success for Anju’s clients and partners. I have been on both sides of clinical research and data management, starting my career at Baxter, Inc.
I enjoy being a part of an industry that helps people live longer and better lives—we must never forget our important role in this process.
Tell us about the services and solutions that Anju Software provides to its clients.
Traditional technology providers offer platform solutions that force customers to adopt their technology their way. At Anju, our technology can be integrated into our customer’s current tools, allowing them to add complementary solutions to their existing environment and create a tailored software experience that perfectly meets their needs.
Anju has deep expertise in three distinct service lines: clinical trials, medical affairs, and data sciences. Anju provides a leading suite of solutions that leverage data- driven analytics to provide a breadth of services to many of the worldwide pharmaceuticals, biotech, and contract research Life Sciences customers & partners.
Anju’s eClinical Suite, Data Science Suite, and Medical Affairs Suite provide comprehensive services and technologies that reduce the complexity of clinical research and the commercialization of drugs and devices.
TrialMaster is the flagship product in Anju’s eClinical Suite, which is the most adaptable clinical solution for life sciences, incorporating best-of-breed applications for all Phases and complexities of clinical trials that can be seamlessly incorporated into our clients’ existing infrastructure.
Anju’s eClinical Suite orchestrates the most intuitive assembly of integrated cross-Phase clinical software. Their eClinical solutions conduct and optimize the functions of class-leading electronic data capture (EDC), clinical trial management system (CTMS), randomization and trial supply management (RTSM / IRT), and, when needed, early-phase data collection (EPS).
Anju’s Medical Affairs Suite provides adaptive, connected, and patient-centric solutions that offer comprehensive, purpose-built capabilities which together unify and enhance the capabilities of medical affairs organizations. Anju’s Medical Affairs suite utilizes a robust platform to elevate medical information, medical communications, and KOL Management to enhance performance, prove value and optimize experiences and outcomes. These platforms include IRMS MAX, iCare MAX, and PubStrat Max.
Anju’s Data Science Suite, TA Scan and TA Scan CRM, delivers comprehensive clinical and commercial intelligence to support Clinical Operations and Medical Affairs teams to make more informed, data-driven decisions around clinical trial design, feasibility, site identification, and KOL identification and management. Our seamless data integration and analytics save research time, spark actionable insights, shorten trial timelines, and accelerate go-to-market strategies.
What were the initial challenges that Anju Software had to overcome, and what are the challenges now?
Clinical development and life sciences data management are undergoing a great transformation. Catalyzed by a global pandemic, technology-driven changes are revolutionizing EDC and data deployment. Anju’s leadership experience in terms of volume over years and types of trials is unparalleled.
Anju’s eClinical Suite, Data Science Suite, and Medical Affairs Suite provide comprehensive services and technologies that reduce internal oversight, simplify vendor management, and reallocate internal personnel resources to higher-priority tasks. And all these services are delivered within a fair and competitive pricing structure.
Under your staunch leadership, what is the vision and mission of Anju Software in the ever-evolving healthcare industry?
At Anju, we strive to put our customers first. Our goal is to provide an exceptional customer experience while delivering scalable technology solutions at a fair price. We want to be the long-term partner helping our customers evolve with industry needs.
These technologies can be complex and require close customer support. We are building a leadership position on the delivery of the best customer experience of anyone else in the industry. We are committed to building support teams that are available to answer complex and simple questions and provide constant support to maximize the value of our technology.
I believe that the health tech revolution has only just begun, and I want to do my part to drive and adopt the changes in digitalization and artificial and machine learning as it continues transforming the life science industry. As vital as our customer-first mission, Anju strives to deliver the best value.
What are the necessary factors and aspects in clinical trials and medical affairs? How does Anju Software stand out as one of the leading companies in this niche?
Traditional technology providers offer platform solutions that force customers to adopt their technology their way. At Anju, the strength of our offerings focuses on delivering solutions specifically for the client’s needs.
Anju’s solutions allow customers to add complementary technologies to their existing environment and create a tailored software experience that perfectly meets their needs. This differentiating service utilizes Anju’s proprietary integration technology.
Anju’s IRMS MAX delivers a new Medical Affairs experience with best-in-class solutions built on the industry’s most robust platform to elevate medical information, medical communications, and KOL Management to enhance performance, prove value and optimize experiences and outcomes.
Anju delivers best-in-class information tools for medical affairs professionals in the form of its IRMS MAX, iCare MAX, and Pubstrat MAX.
Share your opinions on how advanced automated technology is reshaping the modern healthcare industry and how Anju Software is leveraging these emerging technologies to enhance its services and operations.
The increased number of clinical trial endpoints has significantly contributed to the complexity of designing, launching, and completing clinical trials. And, while trial complexity has increased, the demand for faster and cheaper trials, with fewer failures, has also increased. At Anju, all our services are designed to improve trial success by making data easier to share, understand, and use.
For example, Anju’s TrialMaster EDC is the most intuitive Electronic Data Capture (EDC) Suite on the market. TrialMaster EDC features superior usability and flexibility and is an ideal solution for Phase I-IV clinical trials. TrialMaster improves efficiencies and reduces workflow impact while enhancing your data quality, resulting in faster study submission times.
Equally important is Anju’s advanced automated technologies that are providing extreme value in the Medical Affairs business as well as the Data Sciences business.
As mentioned, Anju’s IRMS MAX delivers a new Medical Affairs experience with best-in-class solutions built on the industry’s most robust platform to elevate medical information, medical communications, and KOL Management to enhance performance, prove value, and optimize experiences and outcomes.
Anju’s Data Science Suite, including TA Scan, delivers comprehensive clinical and commercial intelligence to support Clinical Operations and Medical Affairs teams to make more informed, data-driven decisions around clinical trial design, feasibility, site identification, and KOL identification and management. Our seamless data integration and analytics save research time, spark action- able insights, shorten trial timelines, and accelerate go-to- market strategies.
Can you provide any testimonials of your clients/customers that accurately highlights your organization’s position as a prominent company in the sector.
Anju serves 29 of the top 50 pharmaceutical companies and 15 of the top 20 contract research organizations (CROs). Gustave-Roussy, one of the largest oncology research centers in Europe, is ranked #1 outside the U.S. and is ranked #5 globally. With hundreds of oncology clinical trials, Gustave Roussy requires software that can manage the ever-expanding demands of data management. Anju’s TrialMaster allows site researchers, patients, and sponsor staff to access the platform from any device (desktop, laptop, tablet, or smartphone). TrialMaster provides Gustave Roussy researchers with flexible query management as well as sophisticated reporting and data visualization, enabling actionable insights that facilitate better trial oversight across a clinical organization.